Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.9B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.59B |
| 3 |
Apple
AAPL
|
+$2.22B |
| 4 |
Mastercard
MA
|
+$1.77B |
| 5 |
Amazon
AMZN
|
+$1.55B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$93M |
| 2 |
Ares Capital
ARCC
|
+$50.1M |
| 3 |
PNRA
Panera Bread Co
PNRA
|
+$44.1M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$29M |
| 5 |
Pediatrix Medical
MD
|
+$26.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.9% |
| 2 | Healthcare | 14.93% |
| 3 | Financials | 13.48% |
| 4 | Industrials | 12.62% |
| 5 | Consumer Discretionary | 10.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
ON Semiconductor
ON
$34.4B
| $458M | 0.31% |
+32,656,321
| New | +$491M |
|
77
Estee Lauder
EL
$29.1B
| $451M | 0.31% |
4,695,498
+4,431,247
| +1,677% | +$407M |
|
78
UnitedHealth
UNH
$382B
| $443M | 0.3% |
2,388,641
+2,264,242
| +1,820% | +$397M |
|
79
Pfizer
PFE
$140B
| $443M | 0.3% |
13,886,647
+9,844,095
| +244% | +$310M |
|
80
Broadcom
AVGO
$1.84T
| $439M | 0.3% |
18,844,870
+11,030,300
| +141% | +$256M |
|
81
Revvity
RVTY
$12.4B
| $436M | 0.3% |
+6,405,676
| New | +$398M |
|
82
A.O. Smith
AOS
$8.39B
| $430M | 0.29% |
7,631,439
+7,615,943
| +49,148% | +$411M |
|
83
LyondellBasell Industries
LYB
$19.6B
| $428M | 0.29% |
5,067,951
+5,021,985
| +10,925% | +$417M |
|
84
Morgan Stanley
MS
$338B
| $427M | 0.29% |
9,590,843
+9,412,177
| +5,268% | +$406M |
|
|
NATI
85
DELISTED
National Instruments Corp
NATI
| $424M | 0.29% |
+10,541,641
| New | +$384M |
|
86
Cisco
CSCO
$449B
| $423M | 0.29% |
13,528,059
+4,577,831
| +51% | +$149M |
|
87
Aon
AON
$76.8B
| $423M | 0.29% |
3,180,268
+2,917,018
| +1,108% | +$369M |
|
88
Omnicom Group
OMC
$22.6B
| $414M | 0.28% |
4,996,274
+4,963,787
| +15,279% | +$414M |
|
89
Automatic Data Processing
ADP
$99B
| $411M | 0.28% |
4,013,865
+3,947,657
| +5,963% | +$400M |
|
90
Thermo Fisher Scientific
TMO
$207B
| $409M | 0.28% |
2,342,046
+2,233,522
| +2,058% | +$375M |
|
91
Hershey
HSY
$35.4B
| $407M | 0.28% |
3,786,147
+3,767,172
| +19,853% | +$416M |
|
92
Norwegian Cruise Line
NCLH
$9.1B
| $402M | 0.27% |
7,409,748
+7,141,190
| +2,659% | +$369M |
|
|
SCHW
93
Charles Schwab
SCHW
$177B
| $402M | 0.27% |
9,357,736
+8,856,483
| +1,767% | +$355M |
|
94
LPL Financial
LPLA
$26.3B
| $399M | 0.27% |
+9,401,826
| New | +$382M |
|
95
Nice
NICE
$5.28B
| $398M | 0.27% |
+5,050,743
| New | +$374M |
|
96
KLA
KLAC
$284B
| $394M | 0.27% |
43,084,040
+42,906,180
| +24,124% | +$428M |
|
97
Biogen
BIIB
$29.9B
| $392M | 0.27% |
1,445,560
+1,414,707
| +4,585% | +$374M |
|
98
Procter & Gamble
PG
$343B
| $392M | 0.27% |
4,500,564
+4,165,862
| +1,245% | +$367M |
|
99
MSCI
MSCI
$40.4B
| $391M | 0.27% |
3,794,624
+3,785,473
| +41,367% | +$381M |
|
100
Crown Holdings
CCK
$12.7B
| $390M | 0.26% |
6,536,851
+6,443,892
| +6,932% | +$364M |
|
Similar funds
Janus Henderson Group's Q2 2017 Portfolio in Review
As of Q2 2017, Janus Henderson Group held 1,338 positions worth $147B, up 934% from $14.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group deployed $130B of net new capital in Q2 2017, opening 502 new positions and adding to 707 existing holdings. Its largest new stake was Athenahealth, Inc.: 5,079,021 shares worth $714M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Cardinal Health, an estimated $93M trimmed.
- Janus Henderson Group's largest Q2 2017 buy was Athenahealth, Inc.: 5,079,021 shares worth $714M.
- Janus Henderson Group added most to Microsoft in Q2 2017, an estimated $2.9B increase.
- Janus Henderson Group's biggest Q2 2017 reduction was Cardinal Health, cutting an estimated $93M.
- Janus Henderson Group fully exited Yahoo Inc in Q2 2017, selling an estimated $29M.
- Janus Henderson Group's ten largest holdings make up 14% of its $147B portfolio in Q2 2017.
- Janus Henderson Group opened 502 new positions and closed 30 in Q2 2017.
- Janus Henderson Group's portfolio value rose 934% quarter-over-quarter to $147B.
Based on Janus Henderson Group's 13F filing for Q2 2017, filed 14 Aug 2017.